Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes

Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes

BackgroundHepatocellular carcinoma (HCC) accounts for over 80% of primary liver cancers and is the third leading cause of cancer-related deaths worldwide. Hepatitis B virus (HBV) infection is the primary etiological factor. Disulfidptosis is a newly discovered form of regulated cell death. This stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuankuo Zhang, Xing Zhang, Shengjie Dai, Wenjun Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Genetics
Subjects:
disulfidptosis
hepatitis B virus
hepatocellular carcinoma
immunotherapy
prognosis model
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1522484/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items